Current Problems in Cancer
Volume 31, Issue 3 , Pages 157-181 , May 2007

Factors Underlying Disparities in Cervical Cancer Incidence, Screening, and Treatment in the United States

  • Aletha Y. Akers, MD

      Affiliations

    • Robert Wood Johnson Clinical Scholars Program, University of North Carolina, Chapel Hill, North Carolina, USA
    • Corresponding Author InformationAddress correspondence to Dr. Aletha Y. Akers, MD, Robert Wood Johnson Clinical Scholars Program, University of North Carolina, Chapel Hill, NC, USA.
    • ,
  • Sara J. Newmann, MD, MPH

      Affiliations

    • Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts, USA
    • ,
  • Jennifer S. Smith, MPH, PhD

      Affiliations

    • Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina, USA

References 

  1. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase, No. 5, version 2.0. Lyon: IARC Press; 2004;[computer program]
  2. Devesa SS, Silverman DT, Young JL, et al. Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst. 1987;79(4):701–770
  3. Martin LM, Parker SL, Wingo PA, Heath CW. Cervical cancer incidence and screening: status report on women in the United States. Cancer Pract. 1996;4(3):130–134
  4. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers (Also: update 2001–testing for early lung cancer detection). CA Cancer J Clin. 2001;51(1):38–75quiz 77-80
  5. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993;85(12):958–964
  6. Khan MJ, Partridge EE, Wang SS, Schiffman M. Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer. 2005;104(1):61–70
  7. Smith JS, Herrero R, Bosetti C, et al. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst. 2002;94(21):1604–1613
  8. Smith JS, Bosetti C, Munoz N, et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer. 2004;111(3):431–439
  9. Herrero R, Brinton LA, Reeves WC, et al. Invasive cervical cancer and smoking in Latin America. J Natl Cancer Inst. 1989;81(3):205–211
  10. Clarke EA, Hatcher J, McKeown-Eyssen GE, Lickrish GM. Cervical dysplasia: association with sexual behavior, smoking, and oral contraceptive use?. Am J Obstet Gynecol. 1985;151(5):612–616
  11. Larsen NS. Invasive cervical cancer rising in young white females. J Natl Cancer Inst. 1994;86(1):6–7
  12. Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet. 2002;359(9312):1093–1101
  13. Moreno V, Bosch FX, Munoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet. 2002;359(9312):1085–1092
  14. de Villiers EM. Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer. 2003;103(6):705–7081
  15. Smith JS, Green J, Berrington de Gonzalez A, et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet. 2003;361(9364):1159–1167
  16. Sillman F, Stanek A, Sedlis A, et al. The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women. Am J Obstet Gynecol. 1984;150(3):300–308
  17. Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol. 1994;83(2):205–211
  18. Herrero R, Potischman N, Brinton LA, et al. A case-control study of nutrient status and invasive cervical cancer (I. Dietary indicators). Am J Epidemiol. 1991;134(11):1335–1346
  19. Garcia-Closas R, Castellsague X, Bosch X, Gonzalez CA. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer. 2005;117(4):629–637
  20. Butterworth CE, Hatch KD, Macaluso M, et al. Folate deficiency and cervical dysplasia. J Am Med Assoc. 1992;267(4):528–533
  21. ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995). Obstet Gynecol. 2003;102(2):417–427
  22. Hartmann KE, Hall SA, Nanda K, Boggess JF, Zolnoun D. Screening for Cervical Cancer. Systematic Evidence Review. No. 25. Rockville, MD: Agency for Healthcare Research and Quality; 2002;(Prepared by the Research Triangle Institute-University of North Carolina Evidence-based Practice Center under contract No. 290-97-0011), January
  23. Smith RA, Cokkinides V, von Eschenbach AC, et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin. 2002;52(1):8–22
  24. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. Second Edition. Washington DC: U.S. Preventive Services Task Force (USPSTF); 1996;
  25. Shelton D, Paturzo D, Flannery J, Gregorio D. Race, stage of disease, and survival with cervical cancer. Ethn Dis. 1992;2(1):47–54
  26. Janerich DT, Hadjimichael O, Schwartz PE, et al. The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health. 1995;85(6):791–794
  27. Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005;97(9):675–683
  28. Kinney W, Sung HY, Kearney KA, Miller M, Sawaya G, Hiatt RA. Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer (ICC). Gynecol Oncol. 1998;71(3):428–430
  29. Coronado GD, Thompson B, Koepsell TD, Schwartz SM, McLerran D. Use of Pap test among Hispanics and non-Hispanic whites in a rural setting. Prev Med. 2004;38(6):713–722
  30. Mandelblatt J, Andrews H, Kerner J, Zauber A, Burnett W. Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health. 1991;81(5):646–649
  31. Benard VB, Lee NC, Piper M, Richardson L. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States). Cancer Causes Control. 2001;12(1):61–68
  32. Surveillance, Epidemiology, and End Results (SEER) Program. [Public-Use Data 1973-2002, ASCII Text] [computer program]. National Cancer Institute, DCCPS, Surveillance Research Program Cancer Statistics Branch; released April 2005 (based on the November 2004 submission).
  33. Newmann SJ, Garner EO. Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control. 2005;16(1):63–70
  34. Brooks SE, Chen TT, Ghosh A, Mullins CD, Gardner JF, Baquet CR. Cervical cancer outcomes analysis: impact of age, race, and comorbid illness on hospitalizations for invasive carcinoma of the cervix. Gynecol Oncol. 2000;79(1):107–115
  35. Parham GP, Hicks ML. Race as a factor in the outcome of patients with cervical cancer: lift the veil to find the wounded spirit. Gynecol Oncol. 1998;71(2):149–150
  36. Chen JY, Diamant AL, Kagawa-Singer M, Pourat N, Wold C. Disaggregating data on Asian and Pacific Islander women to assess cancer screening. Am J Prev Med. 2004;27(2):139–145
  37. Chen MS. Cancer health disparities among Asian Americans: what we do and what we need to do. Cancer. 2005;104(12):2895–2902(suppl)
  38. Chilton JA, Gor BJ, Hajek RA, Jones LA. Cervical cancer among Vietnamese women: efforts to define the problem among Houston’s population. Gynecol Oncol. 2005;99(3):S203–S206(suppl 1)
  39. Yabroff KR, Lawrence WF, King JC, et al. Geographic disparities in cervical cancer mortality: what are the roles of risk factor prevalence, screening, and use of recommended treatment?. J Rural Health. 2005;21(2):149–157
  40. Farley JH, Hines JF, Taylor RR, et al. Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer. 2001;91(4):869–873
  41. Howell EA, Chen YT, Concato J. Differences in cervical cancer mortality among black and white women. Obstet Gynecol. 1999;94(4):509–515
  42. Patel DA, Barnholtz-Sloan JS, Patel MK, Malone JM, Chuba PJ, Schwartz K. A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of Surveillance, Epidemiology, and End Results data. Gynecol Oncol. 2005;97(2):550–558
  43. del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison T, Trimble E. Ethnic differences in patterns of care of stage 1A(1) and stage 1A(2) cervical cancer: a SEER database study. Gynecol Oncol. 1999;75(1):113–117
  44. Katz A, Eifel PJ, Moughan J, Owen JB, Mahon I, Hanks GE. Socioeconomic characteristics of patients with squamous cell carcinoma of the uterine cervix treated with radiotherapy in the 1992 to 1994 patterns of care study. Int J Radiat Oncol Biol Phys. 2000;47(2):443–450
  45. Merrill RM, Merrill AV, Mayer LS. Factors associated with no surgery or radiation therapy for invasive cervical cancer in Black and White women. Ethn Dis. 2000;10(2):248–256
  46. Grigsby PW, Hall-Daniels L, Baker S, Perez CA. Comparison of clinical outcome in black and white women treated with radiotherapy for cervical carcinoma. Gynecol Oncol. 2000;79(3):357–361
  47. Mundt AJ, Connell PP, Campbell T, Hwang JH, Rotmensch J, Waggoner S. Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol Oncol. 1998;71(2):151–158
  48. Ferrante JM, Gonzalez EC, Roetzheim RG, Pal N, Woodard L. Clinical and demographic predictors of late-stage cervical cancer. Arch Fam Med. 2000;9(5):439–445
  49. Insinga RP, Glass AG, Rush BB. Pap screening in a U.S. health plan. Cancer Epidemiol Biomarkers Prev. 2004;13(3):355–360
  50. Ostbye T, Greenberg GN, Taylor DH, Lee AM. Screening mammography and Pap tests among older American women 1996-2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD). Ann Fam Med. 2003;1(4):209–217
  51. Bazargan M, Bazargan SH, Farooq M, Baker RS. Correlates of cervical cancer screening among underserved Hispanic and African-American women. Prev Med. 2004;39(3):465–473
  52. Breitkopf CR, Pearson HC, Breitkopf DM. Poor knowledge regarding the Pap test among low-income women undergoing routine screening. Perspect Sex Reprod Health. 2005;37(2):78–84
  53. Hewitt M, Devesa SS, Breen N. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey. Prev Med. 2004;39(2):270–278
  54. Jacobs EA, Karavolos K, Rathouz PJ, Ferris TG, Powell LH. Limited English proficiency and breast and cervical cancer screening in a multiethnic population. Am J Public Health. 2005;95(8):1410–1416
  55. Lindau ST, Tomori C, McCarville MA, Bennett CL. Improving rates of cervical cancer screening and Pap smear follow-up for low-income women with limited health literacy. Cancer Invest. 2001;19(3):316–323
  56. Lindau ST, Tomori C, Lyons T, Langseth L, Bennett CL, Garcia P. The association of health literacy with cervical cancer prevention knowledge and health behaviors in a multiethnic cohort of women. Am J Obstet Gynecol. 2002;186(5):938–943
  57. Brooks SE. Cervical cancer screening and the older woman: obstacles and opportunities. Cancer Pract. 1996;4(3):125–129
  58. The National Cancer Institute Cancer Screening Consortium for Underserved Women. Breast and cervical cancer screening among underserved women (Baseline survey results from six states). Arch Fam Med. 1995;4(7):617–624
  59. Calle EE, Flanders WD, Thun MJ, Martin LM. Demographic predictors of mammography and Pap smear screening in US women. Am J Public Health. 1993;83(1):53–60
  60. Anderson LM, May DS. Has the use of cervical, breast, and colorectal cancer screening increased in the United States?. Am J Public Health. 1995;85(6):840–842
  61. Lee J, Parsons GF, Gentleman JF. Falling short of Pap test guidelines. Health Rep. 1998;10(1):9–19
  62. Norman SA, Talbott EO, Kuller LH, et al. The relationship of Papanicolaou testing and contacts with the medical care system to stage at diagnosis of cervical cancer. Arch Intern Med. 1991;151(1):58–64
  63. Kirsner RS, Ma F, Fleming L, et al. The effect of Medicare health care systems on women with breast and cervical cancer. Obstet Gynecol. 2005;105(6):1381–1388
  64. Walter LC, Lewis CL, Barton MB. Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence. Am J Med. 2005;118(10):1078–1086
  65. Thoms WW, Unger ER, Carisio R, et al. Clinical determinants of survival from stage Ib cervical cancer in an inner-city hospital. J Natl Med Assoc. 1998;90(5):303–308
  66. Mitchell PA, Waggoner S, Rotmensch J, Mundt AJ. Cervical cancer in the elderly treated with radiation therapy. Gynecol Oncol. 1998;71(2):291–298
  67. Harlan LC, Greene AL, Clegg LX, Mooney M, Stevens JL, Brown ML. Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol. 2005;23(36):9079–9088
  68. Schmidley D. The Foreign Born Population in the United States: March 2002. Washington DC: U.S. Census Bureau; 2003;
  69. Singh GK, Miller BA. Health, life expectancy, and mortality patterns among immigrant populations in the United States. Can J Public Health. 2004;95(3):I14–I21
  70. Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS. Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med. 2003;18(12):1028–1035
  71. Seeff LC, McKenna MT. Cervical cancer mortality among foreign-born women living in the United States, 1985 to 1996. Cancer Detect Prev. 2003;27(3):203–208
  72. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97(6):1528–1540
  73. Matin M, LeBaron S. Attitudes toward cervical cancer screening among Muslim women: a pilot study. Women Health. 2004;39(3):63–77
  74. Byrd TL, Peterson SK, Chavez R, Heckert A. Cervical cancer screening beliefs among young Hispanic women. Prev Med. 2004;38(2):192–197
  75. McMullin JM, De Alba I, Chavez LR, Hubbell FA. Influence of beliefs about cervical cancer etiology on Pap smear use among Latina immigrants. Ethn Health. 2005;10(1):3–18
  76. Fernandez-Esquer ME, Cardenas-Turanzas M. Cervical cancer screening among Latinas recently immigrated to the United States. Prev Med. 2004;38(5):529–535
  77. Austin LT, Ahmad F, McNally MJ, Stewart DE. Breast and cervical cancer screening in Hispanic women: a literature review using the health belief model. Womens Health Issues. 2002;12(3):122–128
  78. Suarez L, Roche RA, Nichols D, Simpson DM. Knowledge, behavior, and fears concerning breast and cervical cancer among older low-income Mexican-American women. Am J Prev Med. 1997;13(2):137–142
  79. Carey Jackson J, Taylor VM, Chitnarong K, et al. Development of a cervical cancer control intervention program for Cambodian American women. J Community Health. 2000;25(5):359–375
  80. Behbakht K, Lynch A, Teal S, Degeest K, Massad S. Social and cultural barriers to Papanicolaou test screening in an urban population. Obstet Gynecol. 2004;104(6):1355–1361
  81. Chavez LR, Hubbell FA, Mishra SI, Valdez RB. The influence of fatalism on self-reported use of Papanicolaou smears. Am J Prev Med. 1997;13(6):418–424
  82. Taylor VM, Schwartz SM, Jackson JC, et al. Cervical cancer screening among Cambodian-American women. Cancer Epidemiol Biomarkers Prev. 1999;8(6):541–546
  83. Yu ES, Kim KK, Chen EH, Brintnall RA. Breast and cervical cancer screening among Chinese American women. Cancer Pract. 2001;9(2):81–91
  84. Chaudhry S, Fink A, Gelberg L, Brook R. Utilization of papanicolaou smears by South Asian women living in the United States. J Gen Intern Med. 2003;18(5):377–384
  85. Formenti SC, Meyerowitz BE, Ell K, et al. Inadequate adherence to radiotherapy in Latina immigrants with carcinoma of the cervix (Potential impact on disease free survival). Cancer. 1995;75(5):1135–1140
  86. Selden CR, Zorn M, Ratzan SC, Parker RM. Health Literacy. Bethesda, MD: National Library of Medicine; 2000;
  87. Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs, American Medical Association. Health literacy: report of the Council on Scientific Affairs. J Am Med Assoc. 1999;281(6):552–557
  88. Kirsch I, Jungeblut A, Jenkins L, Kolstad A. Adult Literacy in America: A First Look at the Findings of the National Adult Literacy Survey. Washington DC: U.S. Department of Education, Office of Educational Research and Improvement; 1993;
  89. Weiss BD, Hart G, Pust RE. The relationship between literacy and health. J Health Care Poor Underserved. 1991;1(4):351–363
  90. Weiss BD, Hart G, McGee DL, D’Estelle S. Health status of illiterate adults: relation between literacy and health status among persons with low literacy skills. J Am Board Fam Pract. 1992;5(3):257–264
  91. Baker DW, Parker RM, Williams MV, Clark WS, Nurss J. The relationship of patient reading ability to self-reported health and use of health services. Am J Public Health. 1997;87(6):1027–1030
  92. Baker DW, Parker RM, Williams MV, Clark WS. Health literacy and the risk of hospital admission. J Gen Intern Med. 1998;13(12):791–798
  93. Garbers S, Chiasson MA. Inadequate functional health literacy in Spanish as a barrier to cervical cancer screening among immigrant Latinas in New York City. Prev Chronic Dis. 2004;Oct 1(4):A07
  94. McKee MD, Caban A, Burton W, Mulvihill M. Women’s knowledge and experience of atypical Pap results in a high risk community. Women Health. 2002;36(4):19–31
  95. Massad LS, Meyer P, Hobbs J. Knowledge of cervical cancer screening among women attending urban colposcopy clinics. Cancer Detect Prev. 1997;21(1):103–109
  96. Tomaino-Brunner C, Freda MC, Runowicz CD. “I hope I don’t have cancer”: colposcopy and minority women. Oncol Nurs Forum. 1996;23(1):39–44
  97. Rimer BK, Conaway MR, Lyna PR, et al. Cancer screening practices among women in a community health center population. Am J Prev Med. 1996;12(5):351–357
  98. Ho V, Yamal JM, Atkinson EN, Basen-Engquist K, Tortolero-Luna G, Follen M. Predictors of breast and cervical screening in Vietnamese women in Harris County, Houston, Texas. Cancer Nurs. 2005;28(2):119–129
  99. Rodriguez MA, Ward LM, Perez-Stable EJ. Breast and cervical cancer screening: impact of health insurance status, ethnicity, and nativity of Latinas. Ann Fam Med. 2005;3(3):235–241
  100. Bradley CJ, Given CW, Roberts C. Health care disparities and cervical cancer. Am J Public Health. 2004;94(12):2098–2103
  101. Sung JF, Alema-Mensah E, Blumenthal DS. Inner-city African American women who failed to receive cancer screening following a culturally-appropriate intervention: the role of health insurance. Cancer Detect Prev. 2002;26(1):28–32
  102. Bradley CJ, Given CW, Roberts C. Disparities in cancer diagnosis and survival. Cancer. 2001;91(1):178–188
  103. Cornelison TL, Montz FJ, Bristow RE, Chou B, Bovicelli A, Zeger SL. Decreased incidence of cervical cancer in medicare-eligible California women. Obstet Gynecol. 2002;100(1):79–86
  104. Hiatt RA, Pasick RJ, Stewart S, et al. Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med. 2001;33(3):190–203
  105. Breen N, Figueroa JB. Stage of breast and cervical cancer diagnosis in disadvantaged neighborhoods: a prevention policy perspective. Am J Prev Med. 1996;12(5):319–326
  106. Schwartz KL, Crossley-May H, Vigneau FD, Brown K, Banerjee M. Race, socioeconomic status and stage at diagnosis for five common malignancies. Cancer Causes Control. 2003;14(8):761–766
  107. Singh GK, Miller BA, Hankey BF, Edwards BK. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer. 2004;101(5):1051–1057
  108. Liu L, Deapen D, Bernstein L. Socioeconomic status and cancers of the female breast and reproductive organs: a comparison across racial/ethnic populations in Los Angeles County, California (United States). Cancer Causes Control. 1998;9(4):369–380
  109. Barry J, Breen N. The importance of place of residence in predicting late-stage diagnosis of breast or cervical cancer. Health Place. 2005;11(1):15–29
  110. Eschbach K, Mahnken JD, Goodwin JS. Neighborhood composition and incidence of cancer among Hispanics in the United States. Cancer. 2005;103(5):1036–1044
  111. Figueroa JB, Breen N. Significance of underclass residence on the stage of breast or cervical cancer diagnosis. Am Econ Rev. 1995;85(2):112–116
  112. Krieger N, Quesenberry C, Peng T, et al. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988-92 (United States). Cancer Causes Control. 1999;10(6):525–537
  113. Abraido-Lanza AF, Chao MT, Gammon MD. Breast and cervical cancer screening among Latinas and non-Latina whites. Am J Public Health. 2004;94(8):1393–1398
  114. Garner EI. Cervical cancer: disparities in screening, treatment, and survival. Cancer Epidemiol Biomarkers Prev. 2003;12(3):242s–247s
  115. Lockwood-Rayermann S. Characteristics of participation in cervical cancer screening. Cancer Nurs. 2004;27(5):353–363
  116. Benard VB, Eheman CR, Lawson HW, et al. Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001. Obstet Gynecol. 2004;103(3):564–571
  117. O’Malley AS, Mandelblatt J, Gold K, Cagney KA, Kerner J. Continuity of care and the use of breast and cervical cancer screening services in a multiethnic community. Arch Intern Med. 1997;157(13):1462–1470
  118. Hall HI, Jamison PM, Coughlin SS, Uhler RJ. Breast and cervical cancer screening among Mississippi Delta women. J Health Care Poor Underserved. 2004;15(3):375–389
  119. Gulitz E, Bustillo-Hernandez M, Kent EB. Missed cancer screening opportunities among older women: a provider survey. Cancer Pract. 1998;6(6):325–332
  120. Hall HI, Jamison PM, Coughlin SS. Breast and cervical cancer mortality in the Mississippi Delta, 1979-1998. South Med J. 2004;97(3):264–272
  121. Lew AA, Moskowitz JM, Ngo L, et al. Effect of provider status on preventive screening among Korean-American women in Alameda County, California. Prev Med. 2003;36(2):141–149
  122. Cassard SD, Weisman CS, Plichta SB, Johnson TL. Physician gender and women’s preventive services. J Womens Health. 1997;6(2):199–207
  123. Chattopadhyay SK, Ebrahim SH, Tao G, McKenna MT. Use of cervical cancer screening among insured women: the extent of missed opportunities. Health Policy. 2005;73(2):194–201
  124. Lurie N, Margolis KL, McGovern PG, Mink PJ, Slater JS. Why do patients of female physicians have higher rates of breast and cervical cancer screening?. J Gen Intern Med. 1997;12(1):34–43
  125. Jenkins CN, McPhee SJ, Bird JA, et al. Effect of a media-led education campaign on breast and cervical cancer screening among Vietnamese-American women. Prev Med. 1999;28(4):395–406
  126. Jenkins CN, Le T, McPhee SJ, Stewart S, Ha NT. Health care access and preventive care among Vietnamese immigrants: do traditional beliefs and practices pose barriers?. Soc Sci Med. 1996;43(7):1049–1056
  127. McPhee SJ, Stewart S, Brock KC, Bird JA, Jenkins CN, Pham GQ. Factors associated with breast and cervical cancer screening practices among Vietnamese American women. Cancer Detect Prev. 1997;21(6):510–521
  128. Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer. 2000;88(10):2283–2289
  129. Himmelstein DU, Woolhandler S, Hellander I, Wolfe SM. Quality of care in investor-owned vs not-for-profit HMOs. J Am Med Assoc. 1999;282(2):159–163
  130. Benard VB, Lawson HW, Eheman CR, Anderson C, Helsel W. Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet Gynecol. 2005;105(6):1323–1328

PII: S0147-0272(07)00002-5

doi: 10.1016/j.currproblcancer.2007.01.001

Current Problems in Cancer
Volume 31, Issue 3 , Pages 157-181 , May 2007

Article Tools

* Image Usage & Resolution